Phase I trial of intranasal anthrax vaccine (AdVAV)

Trial Profile

Phase I trial of intranasal anthrax vaccine (AdVAV)

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 28 Nov 2017

At a glance

  • Drugs AdVAV (Primary)
  • Indications Anthrax
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Nov 2017 Status changed from planning to not yet recruiting.
    • 05 May 2017 According to aN Altimmune media release, this study is expected to begin during 1Q18 with data anticipated 2Q18.
    • 19 Jan 2017 According to a PharmAthene media release, this study is expected to begin during the second half of 2017 with data anticipated during the first half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top